跳至主要内容
临床试验/CTRI/2020/02/023631
CTRI/2020/02/023631招募中3 期

A study evaluating the efficacy of Axillary Reverse Mapping in biopsy proven patients undergoing upfront surgery - ARM

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Biopsy confirmed early breast cancer with clinical N0/N1 axilla

排除标准

  • 1. Matted nodes in the axilla or locally advanced breast cancer
  • 2.Prior surgeries in the upper limb, axilla or breast
  • 3.Prior treatment for breast cancer including neoadjuvant chemotherapy
  • 4.Pregnant woman
  • 5. Allergies to Indocyanine dye or blue dye

研究者

相似试验